VLDR - Sarepta Therapeutics Velodyne Lidar leads the premarket losers' pack

Sarepta Therapeutics (SRPT) -48% as DMD gene therapy treatment fails to meet primary endpoint.Neoleukin Therapeutics (NLTX) -19% after receiving clinical hold letter from FDA related to CMC assay development for NL-201.Solid Biosciences (SLDB) -18% after Sarepta data misses goal.Sphere 3D (ANY) -12%.Sunworks (SUNW) -8%.Bionano Genomics (BNGO) -8% under pressure on capital raise.Cerecor (CERC) -7% after prices $36.4M stock and warrants offering.3D Systems (DDD) -7%.SPAR Group (SGRP) -5%.Velodyne Lidar (VLDR) -5% on announcing 4Q and FY2020 preliminary snapshot.

For further details see:

Sarepta Therapeutics, Velodyne Lidar leads the premarket losers' pack